PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer

Overview of attention for article published in Frontiers in oncology, June 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 78 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,781 followers.

RT @westermarcklab: @NarlaLabUMich provides elegant evidence how genetic PP2A mutations promote endometrial tumorigenesis. https://t.co/z18…

08 Jul 2019

Reply Repost Favourite

@NarlaLabUMich provides elegant evidence how genetic PP2A mutations promote endometrial tumorigenesis. https://t.co/z186CcemeV PP2A as endometrial tumor suppressor covered also nicely by Veerle Janssens lab https://t.co/KHpo0EAH9z

03 Jul 2019

Reply Repost Favourite

New research: PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer: Over the last decade, the use of targeted therapies has immensely increased in the treatment of cancer. However, treatment for endometrial carcinomas (ECs)… https://t.c

06 Jun 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.